Yancey S B, John S A, Lal R, Austin B J, Revel J P
Division of Biology, California Institute of Technology, Pasadena 91125.
J Cell Biol. 1989 Jun;108(6):2241-54. doi: 10.1083/jcb.108.6.2241.
Analysis by SDS-PAGE of gap junction fractions isolated from heart suggests that the junctions are comprised of a protein with an Mr 43,000. Antibodies against the electroeluted protein and a peptide representing the 20 amino terminal residues bind specifically on immunoblots to the 43-kD protein and to the major products arising from proteolysis during isolation. By immunocytochemistry, the protein is found in ventricle and atrium in patterns consistent with the known distribution of gap junctions. Both antibodies bind exclusively to gap junctions in fractions from heart examined by EM after gold labeling. Since only domains of the protein exposed at the cytoplasmic surface should be accessible to antibody, we conclude that the 43-kD protein is assembled in gap junctions with the amino terminus of the molecule exposed on the cytoplasmic side of the bilayer, that is, on the same side as the carboxy terminus as determined previously. By combining proteolysis experiments with data from immunoblotting, we can identify a third cytoplasmic region, a loop of some 4 kD between membrane protected domains. This loop carries an antibody binding site. The protein, if transmembrane, is therefore likely to cross the membrane four times. We have used the same antisera to ascertain if the 43-kD protein is involved in cell-cell communication. The antiserum against the amino terminus blocked dye coupling in 90% of cell pairs tested; the antiserum recognizing epitopes in the cytoplasmic loop and cytoplasmic tail blocked coupling in 75% of cell pairs tested. Preimmune serum and control antibodies (one against MIP and another binding to a cardiac G protein) had no or little effect on dye transfer. Our experimental evidence thus indicates that, in spite of the differences in amino acid sequence, the gap junction proteins in heart and liver share a general organizational plan and that there may be several domains (including the amino terminus) of the molecule that are involved in the control of junctional permeability.
对从心脏分离出的间隙连接组分进行十二烷基硫酸钠-聚丙烯酰胺凝胶电泳分析表明,这些连接由一种分子量为43,000的蛋白质组成。针对电洗脱蛋白和代表20个氨基末端残基的肽段产生的抗体,在免疫印迹中能特异性地与43-kD蛋白以及分离过程中蛋白水解产生的主要产物结合。通过免疫细胞化学方法,发现该蛋白在心室和心房中的分布模式与已知的间隙连接分布一致。在金标后经电子显微镜检查的心脏组分中,两种抗体都仅与间隙连接结合。由于只有分子暴露于细胞质表面的结构域才能被抗体识别,我们得出结论,43-kD蛋白在间隙连接中组装时,其分子的氨基末端暴露于双层膜的细胞质一侧,即与先前确定的羧基末端在同一侧。通过将蛋白水解实验与免疫印迹数据相结合,我们可以确定第三个细胞质区域,即膜保护结构域之间约4 kD的环。这个环带有一个抗体结合位点。因此,如果该蛋白是跨膜蛋白,它可能跨膜四次。我们使用相同的抗血清来确定43-kD蛋白是否参与细胞间通讯。针对氨基末端的抗血清在90%的测试细胞对中阻断了染料偶联;识别细胞质环和细胞质尾中表位的抗血清在被测试的75%的细胞对中阻断了偶联。免疫前血清和对照抗体(一种针对主要内在蛋白,另一种与心脏G蛋白结合)对染料转移没有或只有很小的影响。因此,我们的实验证据表明,尽管氨基酸序列存在差异,但心脏和肝脏中的间隙连接蛋白具有共同的总体组织模式,并且该分子可能有几个结构域(包括氨基末端)参与连接通透性的控制。